L-p-Bromotetramisole is proposed as a new reagent for use in determining intestinaland (or) placental isoenzymes of alkaline phosphatase in human serum. Its main advantage over L-phenylalanine is its hii discriminating potency at very low concentrations. For highest accuracy, the samples may even be "titrated" with the inhibitor. Analytical recoveries of intestinal and placental isoenzymes in serum are complete, and results correlate well with those by other methods. At the appropriate concentrations, L-p-bromotetramisole gives nearly identical results on a variety of sera, irrespective of the buffer used. Within-day Cv's were 6.1 and 2.1 for 20% and 60% of the resistant isoenzyme activity, respectively.
The purified isoenzymes of human origin we used were the same as those used in a previous study (4) .
Buffer composition and p -nitrophenyiphosphate concentrations were as described earlier (5) , except that the 2-amino-2-methyl-1-propanol buffer was included exactly as very recently proposed for a Selected Method (6) .
L-p -Bromotetramisole All other chemicals used were of the highest purity available.
We measured enzymatic activities and inhibitions with the Beckman-25-Kinetic System (Beckman Instruments, Inc., Fullerton, Calif. 92634). Absorbance was measured every 20s during at least 3 mm and the zA/min at 405 nm was calculated from the slope on the recording. The buffer/substrate reagent was brought to the required temperature (30 #{176}C, unless otherwise specified) before measurement. Electrophoresis in agar gel and starch gel, with subsequent visualization of the isoenzyme pattern, was all done as previously described (7) .
Results

Inhibition by L-p-Bromotetramisole of Purified Human lsoenzymes
As shown in Figure 1 , there is a pronounced distinction in inhibition between the liver-type isoenzymes (liver, kidney, bone, and spleen), which are very sensitive, and the isoenzymes from the intestine and the placenta. The degree of inhibition depends on buffer composition and concentration, being strongest in borate or 0.1 mol/liter N-ethylaminoethanol.
The inhibition is not counteracted by Mg2 (up to 2 mmol/liter) and the D-stereoisomer does not inhibit any 
Inhibition of a Mixture of Sensitive and Resistant
Isoenzymes in Serum by Increasing Concentrations of L-p-Bromotetramisole
To verify that the selected inhibitor concentration is the correct one, we prepared mixtures of a serum containing the isoenzyme of only the liver type (as verified by electrophoresis) and either "Enzatrol" (placental isoenzyme, Dade, Miami) or the purified intestinal isoenzyme. The procedure as outlined revealed 52% of the placental isoenzyme and 50% of the intestinal isoenzyme, respectively. Figure 2 shows that increasing the concentration of L-p-bromotetramisole reveals a strong and parallel inhibition on both samples at concentrations between 4 x i0 and 1 X 10 mol/liter. There is an obvious leveling off of the inhibition between 1 and 2 X 10 mol/ liter and then the inhibition proceeds again, somewhat more pronounced for the sample containing the placental isoenzyme than for the intestinal one. From the curves, it appears that the liver-type isoenzyme is present in both samples in about half of the total activity, which corresponds to the values found by the proposed procedure.
A similar experiment on two samples containing 31% and 63%, respectively, of the resistant-type isoenzymes revealed an inflection point at 67% and 37% inhibition, It is evident from the curves that a complete inhibition of the sensitive isoenzymes requires an inhibitor concentration some 10-fold higher than the concentration for 90% inhibition.
At these relatively high concentrations, inhibition of the intestinal and placental isoenzymes becomes more pronounced. For our purposes we had to select an intermediate concentration at which the inhibition of the sensitive isoenzymes is approximately 90% while the inhibition of the placental and intestinal isoenzymes is 10% in the respective buffer systems.
Final Procedures for the Quantitation of Placental and Intestinal lsoenzyme Activities in Serum
The general procedures used in this study are outlined in Table 1 . Systems A and B have been recently described (5) , whereas systems C and D are a recommended procedure (8) and a Selected Method (6), respectively. The concentrations of the inhibitor were selected from Figure 1 as described above.
To convert the AA/min, derived from the slope on the recording, into U/liter (mo1/liter per minute) the following factors should be used: times 2750 and times 5450, respectively, for N-ethylaminoethanol, 0.1 and 1 mol/liter; times 3300 for diethanolamine; and times 1620 for 2-amino-2-methyl-1-propanol.
These factors are based on the respective volumes of sample and buffer substrate and on a molar absorptivity of p-nitrophenol at 405 nm of 18 500 liter mol' cmt (9) .
For calculation of the placental or intestinal isoenzytne activity, it is assumed that there is 90% inhibition of the activity (x) of the sensitive isoenzymes and 10% of the placental and intestinal isoenzyme activities (y). The total activity before inhibition (a) equals the sum of x andy. The activity remaining after inhibition (b) can then be defined as b 0.lx + O.9y. From both again confirming the percentages found by the previously outlined method.
It is also evident from Figure 2 that varying the final concentration of the inhibitor in system A between 1 and 2 X l0 mol/liter will not result in an appreciable change in the final percentage of the resistant isoenzyme.
It was impossible to detect any inflection point by using increasing concentrations of L-phenylalanine (from 2 to 12 mmol/liter) on two samples containing 54% and 29%, respectively, of the resistant-type isoenzyrne.
Recovery of Placental and Intestinal lsoenzyme Activities
When increasing activities of the placental isoenzyme (Enzatrol) are added to serum containing only the liver-type alkaline phosphatase, the percentages of resistant isoenzyme activity, as calculated from the inhibition by L-p-bromotetramisole, completely correspond to the theoretical values as well as to the values found after heating these samples for 5 mm at 65 #{176}C (10) . This is shown in Figure 3a . We found similar close correspondence between the theoretical percentages and those found by the proposed procedure for mixtures of the purified human intestinal isoenzyme and serum containing only the liver isoenzyme, as shown in Figure  3b .
Effect of Buffer Composition on the inhibition
Thirty samples showing high alkaline phosphatase activities in the routine laboratory were selected for determination of total activity and L-p -bromo- Table  1 .) The samples consisted of sera from pregnant women (n = 11; >34 weeks of gestation), patients on maintenance hemodialysis (n = 12), patients with cirrhosis (n = 3) or acute viral hepatitis (n = 2), one patient with bone metastasis, and finally, one with an isoenzyme of the liver type linked to immunoglobulin G.
We compared the results by Spearman rank correlation.
The total activities of the whole series of samples are correlated in the three systems (r = 0.955 for A to C; P <0.001 and r = 0.949 for A to D; P <0.0001). There is, however, an activation by diethanolamine, which, when compared to the other buffers, shows a significant difference (P = 0.00010) between the pregnancy sera (mean, times 1.43) and the sera from hemodialysis (mean, times 1.66).
The inhibition by L-p-bromotetramisole and the corresponding percentage of placental or intestinal isoenzyme activities are strongly correlated in the three buffer systems (r = 0.993 -0.994; P <0.0001).
The percentages of the resistant type isoenzyme activity are almost equal in buffers A and D, but they are somewhat lower in diethanolainine buffer (-2 to -12%). The results are summarized in Table 2 .
Correlation with L-Pheflylalanifle Inhibition
The inhibition by D-and L-phenylalanine at 5 mmol/liter has been measured on the same 30 samples mentioned above, in system A.
Inhibition by D-phenylalanine ranged from 0 to 13% (mean, 6%) and was not linked to the presence of intestinal or placental isoenzymes.
The inhibition by L-phenylalanine, measured against the D-isomer, is inversely correlated to the inhibition by L-p-bromotetramisole (r = -0.976; P <0.0001). The results are listed in Table 2 . Under identical conditions, the inhibition of sera, containing only the liver isoenzyme, ranges from 12 to 17% (mean 13%) whereas in duodenal fluids (intestinal isoenzyme only) an inhibition was found between 69 and 77% (mean 73%). From the mean values, the percentage of resistant isoenzyme can be calculated the same way as for L-p-bromotetramisole. For the whole group of sera, the percentages found with both inhibitors are correlated (r = 0.977; P <0.0001), but the percentages of placental isoenzyme in the pregnancy sera, as calculated from L-phenylalanine inhibition, are 14% (8 to 18%) higher but only 4% (-2% to +12%) higher in the sera from patients from the Eighty sera from women between 8 and 40 weeks pregnant were analyzed for the placental isoenzyme with use of L-p-bromotetramisole and by heat denaturation (5 mm at 65 #{176}C) in 0.1 mol/liter N-ethylaminoethanol (system A). The correlation between both methods is illustrated in Figure 4 . The Pearson correlation coefficient was found to be 0.923 (n = 79; b = 0.936; a = 0.0553). The one serum not included in the calculation was a sample showing 52% of the placental isoenzyme as found with the inhibitor but only 3% after heat denaturation.
Inspection of that serum revealed a heavy contamination with Achromobacter (these sera were kept frozen for several months before analysis). A subculture of these bacteria showed a strong activity of alkaline phosphatase, which was heat labile but not affected by L-p-bromotetramisole, which explains the discordance between both methods.
Within-run precision of the method was estimated from 15 replicate analyses on two different sera (System A). Sample 1 showed a CV of 3.2% for the total activity A sample kept at 4#{176}C was analyzed for 15 consecutive days. The CV for the total activity was 2.79% (mean: 69 U; SD, 1.92). For the percentage of resistant isoenzyme the CV was found to be 3.45% (mean 53.3%; SD, 1.84).
Application of the Procedure
We analyzed 612 pregnancy sera in system A for the placental isoenzyine activity during gestation. The results ( Figure 5 ) reveal an increase from week 20 up to week 40, but there is considerable scattering. It should be mentioned that many of these samples were kept at -20 #{176}C for four to five months. Bacterial contamination may explain, at least to some extent, the rather high percentages of the placental isoenzyme in some of the samples from the early period of pregnancy.
Nine of the 135 sera (6.6%) from hospitalized male cancer patients showed a resistant isoenzyme activity exceeding 5% of the total activity. A similar experiment on the sera from 126 healthy blood donors revealed a much higher proportion of resistant isoenzyme-positive individuals (63%). In all these cases, only the liver and the intestinal isoenzymes could be identified by electrophoresis.
The intestinal isoenzyme activity in the blood donors is related to blood group, as shown in Figure 6 .
Discussion
In addition to the electrophoretic separation, which undoubtedly provides most useful information, other methods are necessary for the quantitative determination of certain isoenzymes. The most frequently used methods are urea, heat, and L-phenylalanine sensitivity
The application of urea is mainly confined to the discrimination of liver and bone isoenzymes (11, 12) , but suffers from lack of precision.
Heat stability is less clear-cut at the lower temperature (56 #{176}C) but, when sera are kept at 65#{176}C for 5 mm, only the placental isoenzyme remains (10) . Temperature and time of heating must be carefully controlled and a rather large quantity of serum is required. The stability is also affected by pH, buffer, and ionic strength (13, 14) .
Exploiting the inhibition by L-phenylalanine has become popular since its first application to serum (15) and has been recently proposed for routine measurements on automated enzyme analyzers (11, 12) . The inhibition of the placental and intestinal isoenzyme activity is, however, far from complete (55-65%) at concentrations inhibiting the liver or bone isoenzymes by less than 10%. Furthermore, relatively high concentrations are needed and the solubility is insufficient to prepare an adequate solution which, in a kinetic assay, could be added into the cuvette without an appreciable change in the total volume. It is also necessary to have a parallel run with D-phenylalanine whose nonspecific inhibition could vary between 0 and 13%. Thus, using phenylalanine, a valuable determination of the intestinal and placental isoenzyme activity in serum requires three separate and very accurate measurements.
As far as organ specificity is concerned, the inhibition of the human alkaline phosphatase isoenzymes by Lp-bromotetramisole is the reverse of the inhibition by L-phenylalanine and occurs at 500-fold lower concentrations. This very low final concentration for an almost complete inhibition of the sensitive isoenzymes is unlikely to change the ionic environment in the medium. The D-stereoisomer does not inhibit any activity at concentrations exceeding 100 times those used for Lp-bromotetramisole.
The potency and the excellent solubility in water (>0.1 mol/liter) allow the addition, in a kinetic system, of a solution amounting to only 1% of the final volume, so that no correction has to be applied for dilution. Measurement of the sensitive isoenzyme activity may thus proceed subsequent to the de-termination of the total activity, obviating a second sampling and buffer substrate solution. The result is better precision and a considerable reduction in time and cost per determination.
The discriminating potency is much higher than for L-phenylalanine, as is most clearly illustrated by the possibility of "titrating" a mixture of sensitive and resistant isoenzymes in serum. It also follows that small changes in the quantity of the inhibitor are not critical.
The concentration of L-p-bromotetramisole depends on the buffer used because of the antagonism between inhibition and buffer activation (4) . At the appropriate inhibitor concentration, the final resistant isoenzyme activities in different buffer systems are strongly correlated. They are, however, quantitatively lower in diethanolamine buffer, most probably due to different activation by this buffer of the respective isoenzymes (4).
There is a strong (but inverse) correlation between inhibition by L-p-bromotetramisole and L-phenylalanine on a variety of sera. In the pregnancy sera, the percentages of resistant type isoenzyme, calculated from L-phenylalanine inhibition, are higher by 8 to 18%. One reason might be a difference in inhibition by L-phenylalanine between the placental and the intestinal isoenzyme under the conditions used, whereas a common factor has been assumed for calculation. Such a difference would not affect the results with bromotetramisole, which does not affect those isoenzyme activities. The accuracy of the procedure can be regarded as acceptable because recoveries and, for the placental isoenzyme, the correlation with heat denaturation are excellent.
When applied to sera from pregnant women, the rise of the placental isoenzyme activity from week 20 to week 40 of gestation, previously reported from use of other techniques (16, 17) , could be confirmed.
The validity of the procedure is further illustrated by the results on sera from hospitalized patients and healthy blood donors. In the latter group, the intestinal isoenzyme activities range between 0 and 37%, which is comparable with values reported elsewhere (18) (19) (20) (21) . The linkage of this activity to the blood group confirms the findings of other authors (1, 22) . The much higher frequency of measurable intestinal isoenzyme activity in sera from blood donors than in sera from hospitalized patients has already been described, with use of Lphenylalanmne (23) .
A disadvantage of the procedure is the lack of discrimination of the placental and the intestinal isoenzymes. Bacterial growth should be avoided because no non-mammalian alkaline phosphatase has yet been found to be sensitive to this class of inhibitors.
We conclude that -p -bromotetramisole is a useful reagent for routine quantitative determination of the placental or intestinal isoenzyme activities of alkaline phosphatase in serum. In the research units, its application may facilitate studies on the factors involved in the release of these isoenzymes into the blood stream or other body fluids.
